Somerville, MA, United States of America

Zhan Wang

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Flagship Pioneering Innovations Vi, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhan Wang. Retrieved from https://idiyas.com/inventor/zhan-wang-sv7ysjbo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhan Wang: Innovator in Gene Modifying Systems

Introduction

Zhan Wang is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of gene editing, particularly in the development of systems aimed at treating genetic disorders.

Latest Patents

Zhan Wang holds a patent for "CFTR-modulating compositions and methods." This patent provides compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at specific locations within a DNA sequence. The gene modifying systems described in this patent are particularly focused on treating cystic fibrosis, especially in subjects with the F508del mutation. He has 1 patent to his name.

Career Highlights

Zhan Wang is associated with Flagship Pioneering Innovations Vi, LLC, where he continues to work on groundbreaking innovations in genetic research. His work is pivotal in advancing therapeutic options for genetic diseases.

Collaborations

Zhan Wang collaborates with esteemed colleagues, including Robert Charles Altshuler and Anne Helen Bothmer, contributing to a dynamic research environment that fosters innovation.

Conclusion

Zhan Wang's contributions to gene editing and his innovative patent for CFTR-modulating compositions highlight his role as a key figure in the field of genetic research. His work promises to pave the way for new treatments for cystic fibrosis and other genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…